PrezerGen Bioscience is dedicated to the preservation of customers’ live tissues in a clinically compliant manner for future uses and the generation of genetically-compatible cell lines via stem cell techniques for therapeutic purposes Startup/business
PrezerGen Biosciences is established to provide fundamental resources to the emerging market of stem cell-based regenerative medicine. The technology that forms the basis of PrezerGen's business was discovered in 2007 and changed the way biologists have viewed stem cells and development. As an early company in this field, PrezerGen will play a key role in promoting the ability to generate patient-specific stem cell lines. Patient-specific cells lines can be used to develop cells or tissues to treat diseases via imminent cell replacement technologies with no risk of immune rejection. PrezerGen Biosciences' services will also generate applications for research, drug-screening, and genetic analysis. The PrezerGen management and advisors recognize the potential of this market and are active in moving it forward. PrezerGen offers a practical solution for both investors and customers that want to take advantage of new and emerging stem cell technologies today.